PRRs, as lipopolysaccharides (LPS) produced by gut bacteria, can activate Toll-like receptor 4 (TLR4), thus inducing a series of inflammatory reactions to influence the development of liver cancer [1]. This evidence concerns the gene TLR4 and liver cancer.